Effectiveness of Virtual Reality Rehabilitation to Improve Cognitive, Emotional, Relational, and Motor Domains in Patients With Neurological and Neurodegenerative Disorders

Running, not recruitingNot a drug-phase studyMS (type not specified)NCT06838975

What it found

Still running

No result yet.

What was tested

Treatment tested

  • VR Training

Compared with

  • traditional cognitive and motor rehabilitation following standard clinical practices

What it measured

Main measures

  • Improvement in Cognitive Function

    Baseline (T0), Post-Intervention (T1: 8 weeks), and Follow-Up (T2: 3 months post-intervention).

    MRI lesionsThinking and memory
  • Improvement in Motor Function

    Baseline (T0), Post-Intervention (T1: 8 weeks), and Follow-Up (T2: 3 months post-intervention).

    MRI lesionsWalking and mobility

Other measures (2)

  • Neurophysiological Changes Associated with Rehabilitation

    Baseline (T0), Post-Intervention (T1: 8 weeks), and Follow-Up (T2: 3 months post-intervention).

    MRI lesionsNerve conduction tests
  • Effectiveness of Telerehabilitation

    Baseline (T0), Post-Intervention (T1: 8 weeks), and Follow-Up (T2: 3 months post-intervention)

    MRI lesionsThinking and memoryQuality of life (reported by participants)Feasibility

Who could take part

MS (type not specified) · 18 to 75

Show the full criteria

Inclusion criteria

* Age: 18 to 75 years * Diagnosis: Parkinson's Disease (PD) (MDS Clinical Diagnostic Criteria) Multiple Sclerosis (MS) (McDonald Criteria) Spinal Cord Injury (SCI) (ASIA Impairment Scale) Acquired Brain Injury (ABI) (WHO Criteria for Stroke) * Education: Minimum of 5 years of formal education * Cognitive and physical ability to engage in rehabilitation

Exclusion criteria

* Major psychiatric disorders (e.g., psychosis, severe depression, anxiety disorders) * Severe medical conditions that impair participation * Sensory or motor impairments preventing VR interaction * Contraindications for MRI (e.g., pacemakers, incompatible implants) * Pregnancy

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This randomized controlled trial (RCT) evaluates the effectiveness of virtual reality (VR) rehabilitation in improving cognitive, emotional, social, and motor functions in patients with neurological disorders (ABI, SCI, MS, PD). It investigates whether VR improves motor and cognitive functions more than traditional therapy, identifies neurophysiological changes (EEG, fNIRS, MRI), and assesses the integration of VR with NIBS or telerehabilitation. Conducted over three years at IRCCS Centro Neurolesi Bonino Pulejo, participants are randomly assigned to either a VR training group or an active control group receiving traditional rehabilitation. Procedures include baseline assessments (T0), 20 rehabilitation sessions over 8 weeks, post-intervention evaluations (T1), and a 3-month follow-up (T2). Primary outcomes measure motor and cognitive function (MoCA, MMSE, FIM, TUG, Berg Balance Scale), neurophysiological changes (EEG, MRI, fNIRS, motion analysis), and emotional/social function (Empathy Quotient, Hamilton Depression Scale).

Papers

Loading reviews and guidelines…

History

    1. Started

      Jan 2025

    2. Main results due

      Sept 2027

    3. Finished

      Jan 2028

    Assembled by software from public sources.